Eurofins Scientific SE
ERF
株式のランク
#1411
Eurofins Scientific SE, together with its subsidiaries, provides various... Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
株価
$90.13
時価総額
$15.65B
変化（1日）
-3.81%
変化（1年）
24.32%
国
LU
取引 Eurofins Scientific SE (ERF)
カテゴリー
Healthcare
Eurofins Scientific SE（ERF）の収益
Jun 2026 時点の収益 TTM: $8.76B
Eurofins Scientific SE の最新の財務報告によると、現在の収益 (TTM) は $8.76B です。2024 年には $7.23B の収益があり、これは 2023 年の $7.20B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Eurofins Scientific SE の収益履歴（2002 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $8.76B | 2.33% |
| 2025 | $8.56B | 18.35% |
| 2024 | $7.23B | 0.43% |
| 2023 | $7.20B | 0.02% |
| 2022 | $7.20B | -5.75% |
| 2021 | $7.64B | 15.33% |
| 2020 | $6.62B | 29.39% |
| 2019 | $5.12B | 17.82% |
| 2018 | $4.35B | 21.87% |
| 2017 | $3.57B | 33.59% |
| 2016 | $2.67B | 26.05% |
| 2015 | $2.12B | 24.10% |
| 2014 | $1.71B | 1.24% |
| 2013 | $1.69B | 22.39% |
| 2012 | $1.38B | 28.33% |
| 2011 | $1.07B | 17.97% |
| 2010 | $909.59M | -0.89% |
| 2009 | $917.78M | 4.08% |
| 2008 | $881.83M | 22.68% |
| 2007 | $718.83M | 48.46% |
| 2006 | $484.20M | 75.80% |
| 2005 | $275.43M | 15.73% |
| 2004 | $238.00M | 12.05% |
| 2003 | $212.41M | 25.25% |
| 2002 | $169.59M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.34B | 428.96% |
US
|
|
| $25.11B | 186.62% |
US
|
|
| $2.71B | -69.10% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -15.84% |
US
|
